News

Dr. Zachary Hartman Receives NIH Funding for Novel Cancer Therapy

Zachary Hartman, PhD, Assistant Professor of Surgery, Division of Surgical Sciences, has received an R01 award from the National Institutes of Health (NIH) for his proposal "Enabling effective anti-tumor immunity from targeted antibodies through dual innate and adaptive immune checkpoint blockade in non-immunogenic cancers."

Dr. Beasley Receives DCI Award for Poliovirus in Melanoma Research

Georgia Beasley, MD, MHS, Assistant Professor of Surgery in the Division of Surgical Oncology, has received a 2019 award from the Duke Cancer Institute (DCI) for her pilot research project, “Oncolytic Poliovirus in Melanoma.”

Using an oncolytic poliovirus has already been tested at Duke as a treatment for recurrent glioblastoma, and in Dr. Beasley’s current research, the therapy will be used for treatment refractory melanoma, or melanoma that has not responded to other treatments. 

Duke Transplant Center Funding Opportunity

The Duke Transplant Center (DTC) of the Duke University School of Medicine aims to promote cross-disciplinary clinical, translational, and basic research with the ultimate goal of optimizing transplant organ longevity and improving quality of life of transplant recipients. This is the inaugural annual call from the DTC for proposals for pilot and feasibility studies.

Duke Surgery Holds 4th Annual Research Day

The Department of Surgery held its 4th Annual Research Day April 17. The department holds this event annually to advance its mission of improving patient care through research and training the next generation of surgeon–scientists. The event recognizes the accomplishments of fellows, residents, and students engaged in clinical or basic and translational research through the department.

Duke Surgery Ranks First Nationwide in NIH Funding

The Blue Ridge Institute for Medical Research has released its 2018 rankings of NIH funding for basic and clinical science departments, revealing that Duke Surgery ranks highest nationwide with more than $30 million in funding committed to research.

Cancer Cells Steer a Jagged Path

A jagged little protein appears to be a key to how cancer stem cells differentiate and enable metastasis, according to researchers at Duke Cancer Institute and Rice University.